Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

278 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Asymmetric dimethylarginine, a biomarker of cardiovascular complications in diabetes mellitus.
Konya H, Miuchi M, Satani K, Matsutani S, Yano Y, Tsunoda T, Ikawa T, Matsuo T, Ochi F, Kusunoki Y, Tokuda M, Katsuno T, Hamaguchi T, Miyagawa J, Namba M. Konya H, et al. Among authors: ikawa t. World J Exp Med. 2015 May 20;5(2):110-9. doi: 10.5493/wjem.v5.i2.110. eCollection 2015 May 20. World J Exp Med. 2015. PMID: 25992325 Free PMC article. Review.
Profile of saxagliptin in the treatment of type 2 diabetes: focus on Japanese patients.
Konya H, Yano Y, Matsutani S, Tsunoda T, Ikawa T, Kusunoki Y, Matsuo T, Miuchi M, Katsuno T, Hamaguchi T, Miyagawa J, Namba M. Konya H, et al. Among authors: ikawa t. Ther Clin Risk Manag. 2014 Jul 11;10:547-58. doi: 10.2147/TCRM.S46076. eCollection 2014. Ther Clin Risk Manag. 2014. PMID: 25050065 Free PMC article. Review.
Effect of additional administration of acarbose on blood glucose fluctuations and postprandial hyperglycemia in patients with type 2 diabetes mellitus under treatment with alogliptin.
Kusunoki Y, Katsuno T, Myojin M, Miyakoshi K, Ikawa T, Matsuo T, Ochi F, Tokuda M, Murai K, Miuchi M, Hamaguchi T, Miyagawa J, Namba M. Kusunoki Y, et al. Among authors: ikawa t. Endocr J. 2013;60(4):431-9. Epub 2012 Dec 5. Endocr J. 2013. PMID: 23220949 Free article. Clinical Trial.
Case report: Nodular scleroderma successfully treated with tocilizumab.
Takahashi T, Takahashi T, Ueki M, Terui H, Segawa Y, Ikawa T, Takahashi T, Kambayashi Y, Asano Y. Takahashi T, et al. Among authors: ikawa t. Int J Rheum Dis. 2024 May;27(5):e15200. doi: 10.1111/1756-185X.15200. Int J Rheum Dis. 2024. PMID: 38794840 No abstract available.
Safety and Feasibility of Combining On-Demand Selective Locoregional Treatment with First-Line Atezolizumab Plus Bevacizumab for Patients with Unresectable Hepatocellular Carcinoma.
Nakabori T, Higashi S, Abe Y, Mukai K, Ikawa T, Konishi K, Maeda N, Nakanishi K, Hasegawa S, Wada H, Ohkawa K. Nakabori T, et al. Among authors: ikawa t. Curr Oncol. 2024 Mar 15;31(3):1543-1555. doi: 10.3390/curroncol31030117. Curr Oncol. 2024. PMID: 38534950 Free PMC article.
278 results